Shi Lei, Wang Yu-Fang, Zhang Guo-Feng, Li Yan, Yao Ming-Li, Li Jing-Chao, Qiu Chun-Fang, Yao Shun, Ouyang Bin, Wang Ling-Yan
Division of Neurosurgical Intensive Care Unit, Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
Neurosurg Rev. 2025 Feb 28;48(1):274. doi: 10.1007/s10143-025-03425-0.
Polyuria, or excessive fluid loss through the kidneys, is a common issue in neurocritical patients, often resulting from conditions such as fluid volume overload, osmotic diuretics, central diabetes insipidus (CDI), or cerebral salt wasting syndrome (CSWS). Notably, the specific cause of postoperative polyuria within 24 h in patients with tumors located in the supratentorial non-midline region remains poorly understood. To address this gap, we conducted a prospective observational study with 30 patients and found that eight (26.7%) experienced postoperative polyuria. Binary logistic regression analysis of clinical data ruled out fluid volume and osmotic diuretics as the underlying causes of postoperative polyuria, and suggested a very subtle association between tumor size and polyuria (OR = 1.030; p = 0.041). A significant postoperative decrease in serum sodium levels in the polyuria group (p = 0.005) pointed towards CSWS as potential mechanism. Differentiating between CDI and CSWS, both involving neuroendocrine hormone dysregulation, is challenging due to the lack of efficient clinical tests. To overcome this, we developed a novel liquid chromatography-tandem mass spectrometry (LC-MS)-based targeted and quantitative method to measure seven neuroendocrine hormones, including antidiuretic hormone (ADH) related to CDI and six natriuretic peptides associated with CSWS. Elevated levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), and ADH were observed in the polyuria group. Univariate analysis identified ANP, BNP, and ADH as significantly associated with polyuria at a threshold of p < 0.1. Later, multivariate logistic regression further revealed elevated BNP as an independent risk factor for polyuria (OR = 9111.901; p = 0.022). These findings suggest that CSWS may be the primary cause of postoperative polyuria in patients with supratentorial non-midline tumors, as evidenced by the concomitant decrease in serum sodium and increase in natriuretic peptides, particularly BNP.
多尿,即通过肾脏过多流失体液,是神经重症患者中的常见问题,通常由诸如液体量超负荷、渗透性利尿剂、中枢性尿崩症(CDI)或脑性盐耗综合征(CSWS)等情况引起。值得注意的是,幕上非中线区域肿瘤患者术后24小时内出现多尿的具体原因仍知之甚少。为了填补这一空白,我们对30例患者进行了一项前瞻性观察研究,发现8例(26.7%)出现术后多尿。对临床数据进行二元逻辑回归分析排除了液体量和渗透性利尿剂作为术后多尿的潜在原因,并提示肿瘤大小与多尿之间存在非常微妙的关联(OR = 1.030;p = 0.041)。多尿组术后血清钠水平显著下降(p = 0.005),表明CSWS可能是潜在机制。由于缺乏有效的临床检测方法,区分均涉及神经内分泌激素失调的CDI和CSWS具有挑战性。为了克服这一问题,我们开发了一种基于液相色谱 - 串联质谱(LC-MS)的新型靶向定量方法,用于测量七种神经内分泌激素,包括与CDI相关的抗利尿激素(ADH)和与CSWS相关的六种利钠肽。在多尿组中观察到心房利钠肽(ANP)、脑利钠肽(BNP)、C型利钠肽(CNP)和ADH水平升高。单因素分析确定ANP、BNP和ADH在p < 0.1的阈值下与多尿显著相关。随后,多因素逻辑回归进一步显示BNP升高是多尿的独立危险因素(OR = 9111.901;p = 0.022)。这些发现表明,CSWS可能是幕上非中线肿瘤患者术后多尿的主要原因,血清钠降低和利钠肽增加,特别是BNP增加可作为证据。